Nifty
:
11896.80
Sensex
:
40544.37
23.75 (0.20%)
112.77 (0.28%)
Nifty
Sensex
:
:
11896.80
40544.37
23.75 (0.20%)
112.77 (0.28%)

Pharmaceuticals & Drugs - Global

Rating :
67/99  (View)

BSE: 540025 | NSE: ADVENZYMES

NSE BSE
320.20
-9.85 (-2.98%)
20-Oct-2020 | 3:58PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  330.00
  •  330.30
  •  318.00
  •  330.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  234047
  •  749.42
  •  384.70
  •  98.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,677.01
  • 28.25
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,619.54
  • 0.18%
  • 4.22

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 55.45%
  • 0.54%
  • 14.32%
  • FII
  • DII
  • Others
  • 16.01%
  • 6.26%
  • 7.42%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.35
  • 8.61
  • 4.33

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 24.34
  • 8.11
  • 4.43

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 22.73
  • 11.26
  • 12.77

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 18.68

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 3.46

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 12.76

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
110
110
0%
110
110
0%
112
102
10%
111
103
8%
Expenses
59
57
3%
62
61
1%
59
60
-2%
64
61
5%
EBITDA
52
53
-3%
49
50
-2%
53
42
27%
47
42
12%
EBIDTM
47%
48%
14%
45%
47%
41%
42%
41%
Other Income
5
1
393%
2
3
-30%
1
0
256%
2
2
-24%
Interest
0
1
-44%
1
1
19%
1
0
0
1
2
-67%
Depreciation
7
6
7%
7
5
26%
6
5
18%
6
5
23%
PBT
50
47
5%
43
46
-7%
47
37
28%
42
37
14%
Tax
15
14
11%
11
13
-19%
12
11
9%
10
11
-9%
PAT
35
34
2%
33
33
-2%
35
25
36%
32
26
23%
PATM
32%
31%
7%
30%
31%
25%
29%
25%
EPS
3.12
3.04
3%
2.93
3.00
-2%
3.09
2.27
36%
2.85
2.32
23%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
444
444
420
391
329
294
223
239
220
172
116
Net Sales Growth
4%
6%
7%
19%
12%
32%
-7%
9%
28%
48%
 
Cost Of Goods Sold
4,709
81
77
81
71
62
48
48
52
48
47
Gross Profit
-4,265
363
342
310
258
232
175
192
168
123
69
GP Margin
-960%
82%
82%
79%
78%
79%
79%
80%
76%
72%
60%
Total Expenditure
244
241
237
227
178
156
133
138
130
110
93
Power & Fuel Cost
-
19
20
18
13
10
10
15
16
13
9
% Of Sales
-
4%
5%
5%
4%
3%
5%
6%
7%
7%
8%
Employee Cost
-
80
80
69
51
44
37
33
27
20
13
% Of Sales
-
18%
19%
18%
15%
15%
16%
14%
12%
12%
12%
Manufacturing Exp.
-
17
12
12
10
11
11
4
6
5
7
% Of Sales
-
4%
3%
3%
3%
4%
5%
2%
3%
3%
6%
General & Admin Exp.
-
26
29
28
18
16
18
21
18
13
10
% Of Sales
-
6%
7%
7%
5%
5%
8%
9%
8%
7%
9%
Selling & Distn. Exp.
-
11
10
10
8
7
6
5
5
4
5
% Of Sales
-
2%
2%
2%
2%
2%
3%
2%
2%
2%
4%
Miscellaneous Exp.
-
7
9
9
8
6
4
12
6
7
5
% Of Sales
-
2%
2%
2%
2%
2%
2%
5%
3%
4%
1%
EBITDA
201
203
183
164
151
138
91
101
91
62
23
EBITDA Margin
45%
46%
44%
42%
46%
47%
41%
42%
41%
36%
20%
Other Income
10
6
6
3
3
1
3
2
4
3
4
Interest
3
4
5
9
4
8
9
13
10
12
2
Depreciation
26
26
21
18
13
9
9
10
7
6
5
PBT
181
179
162
139
137
122
75
80
77
48
19
Tax
48
46
46
45
44
41
23
7
26
13
2
Tax Rate
26%
26%
28%
33%
32%
35%
31%
26%
34%
28%
12%
PAT
134
129
111
90
92
76
51
20
50
34
17
PAT before Minority Interest
131
133
116
94
93
77
52
21
51
34
17
Minority Interest
-2
-4
-5
-3
-1
-1
-1
-1
-1
0
0
PAT Margin
30%
29%
26%
23%
28%
26%
23%
8%
23%
20%
14%
PAT Growth
13%
16%
23%
-1%
21%
49%
158%
-60%
48%
102%
 
EPS
11.99
11.58
9.94
8.07
8.19
6.79
4.56
1.77
4.46
3.02
1.49

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
840
679
559
464
278
212
167
163
97
63
Share Capital
22
22
22
22
22
22
22
22
21
21
Total Reserves
814
653
534
441
256
190
146
142
76
43
Non-Current Liabilities
44
30
43
32
56
64
94
130
146
44
Secured Loans
3
6
17
16
35
49
82
108
132
28
Unsecured Loans
1
1
2
3
4
5
6
8
7
9
Long Term Provisions
1
1
1
1
0
0
0
0
0
0
Current Liabilities
60
70
103
65
111
131
133
100
105
45
Trade Payables
10
10
17
11
12
12
10
17
18
8
Other Current Liabilities
34
34
42
25
59
83
60
44
42
7
Short Term Borrowings
13
21
38
27
30
24
39
33
38
27
Short Term Provisions
4
5
6
3
10
13
23
7
6
3
Total Liabilities
971
805
727
583
450
412
398
396
349
154
Net Block
568
495
491
421
285
282
115
116
50
51
Gross Block
680
586
561
445
358
346
172
163
89
87
Accumulated Depreciation
113
91
70
24
72
64
57
47
39
35
Non Current Assets
596
518
512
440
311
307
306
302
273
90
Capital Work in Progress
10
10
11
8
7
9
173
173
215
19
Non Current Investment
0
0
0
0
0
0
0
0
0
0
Long Term Loans & Adv.
17
11
9
9
18
16
8
12
8
20
Other Non Current Assets
1
1
1
1
0
0
9
1
0
0
Current Assets
376
287
216
143
140
104
92
94
77
64
Current Investments
124
111
0
0
0
0
0
0
0
0
Inventories
80
77
76
68
60
53
50
45
29
18
Sundry Debtors
75
59
59
50
42
37
32
39
32
22
Cash & Bank
83
23
61
8
26
4
3
3
5
15
Other Current Assets
14
14
13
8
11
10
7
7
10
9
Short Term Loans & Adv.
7
3
7
9
3
9
7
7
10
9
Net Current Assets
316
216
113
78
29
-27
-41
-6
-28
18
Total Assets
971
805
727
583
450
412
398
396
349
154

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
141
129
116
107
93
54
56
41
88
1
PBT
179
162
139
137
118
75
28
77
48
19
Adjustment
28
26
27
18
15
17
21
15
17
6
Changes in Working Capital
-16
-12
-6
4
-13
-12
26
-26
37
-19
Cash after chg. in Working capital
192
176
160
160
120
80
75
67
101
6
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
-51
-47
-45
-52
-27
-26
-19
-25
-12
-4
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
-44
-125
-78
-60
-5
-11
-9
-30
-200
-18
Net Fixed Assets
-46
-5
-9
62
-6
-6
-6
-14
-41
Net Investments
0
0
-17
-50
-26
1
0
-14
-9
Others
2
-120
-52
-72
27
-6
-3
-1
-150
Cash from Financing Activity
-39
-43
-2
-65
-63
-36
-33
-5
100
30
Net Cash Inflow / Outflow
58
-39
36
-18
26
6
13
7
-12
13
Opening Cash & Equivalents
23
61
8
25
4
2
3
5
15
2
Closing Cash & Equivalent
83
23
61
8
25
4
2
3
5
15

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
75
60
50
42
26
19
15
15
9
6
ROA
15%
15%
14%
18%
18%
13%
5%
14%
14%
11%
ROE
18%
19%
18%
25%
31%
27%
13%
39%
43%
27%
ROCE
23%
25%
26%
32%
36%
25%
12%
27%
28%
17%
Fixed Asset Turnover
0.70
0.73
0.79
0.85
0.86
0.90
1.48
1.83
2.03
1.42
Receivable days
55
51
50
49
47
55
52
56
56
66
Inventory Days
65
66
66
69
68
81
70
58
48
53
Payable days
14
23
25
25
29
34
39
56
49
36
Cash Conversion Cycle
105
94
92
92
86
102
82
58
55
83
Total Debt/Equity
0.03
0.05
0.12
0.12
0.36
0.54
0.99
1.13
2.13
1.03
Interest Cover
45
32
16
32
16
9
3
9
5
9

Annual Reports:

Financial Year 2019
Financial Year 2018
Financial Year 2017
Financial Year 2016
Financial Year 2015
Financial Year 2014
Financial Year 2013
Financial Year 2012

News Update


  • Advanced Enzyme - Quarterly Results
    12th Aug 2020, 12:23 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.